Background: Dietary carotenoids may have independent positive impacts on a range of health-related outcomes such as obesity. The purpose of this study was to examine the associations between individual and total dietary carotenoids and the likelihood of being overweight or obese.
Methods: Dietary intakes of 4202 participants of the PERSIAN cohort study were investigated by a 237-item FFQ, and carotenoid intake was determined using the USDA food databases. Models of logistic regression were applied to assess the association between obesity and overweight and dietary intake of carotenoids after adjusting for confounders.
Results: Higher total carotenoid intake was associated with reduced risk of overweight (energy-adjusted OR: 0.647, 95% CI: 0.429-0.975, P = 0.037) and obesity (energy-adjusted OR: 0.395, 95% CI: 0.244-0.640, P < 0.001). Specific individual carotenoids, including β-carotene (OR: 0.510, 95% CI: 0.356-0.731, P < 0.001), lutein/zeaxanthin (OR: 0.479, 95% CI: 0.331-0.692, P < 0.001), and phytoene (OR = 0.450, 95% CI = 0.306-0.661, P < 0.001) exhibited stronger inverse associations compared to lycopene and astaxanthin.
Conclusion: Diets rich in specific carotenoids, particularly β-carotene, lutein, and phytoene, may reduce the risk of both overweight and obesity. Future research ought to examine the mechanisms behind the relations of carotenoids with public health issues.
{"title":"Dietary intake of individual and total carotenoids in relation to overweight and obesity: findings from the PERSIAN cohort study.","authors":"Majid Kamali, Golsa Khalatbari Mohseni, Mahsa Shapouri, Masoomeh Alsadat Mirshafaei, Yeganeh Shekari, Malikeh Mohajerani, Torsten Bohn, Ali Nouri, Faezeh Tejareh, Barbod Alhouei, Maryam Gholamalizadeh, Farhad Vahid, Akram Kooshki, Saeid Doaei","doi":"10.1186/s12986-025-01059-z","DOIUrl":"10.1186/s12986-025-01059-z","url":null,"abstract":"<p><strong>Background: </strong>Dietary carotenoids may have independent positive impacts on a range of health-related outcomes such as obesity. The purpose of this study was to examine the associations between individual and total dietary carotenoids and the likelihood of being overweight or obese.</p><p><strong>Methods: </strong>Dietary intakes of 4202 participants of the PERSIAN cohort study were investigated by a 237-item FFQ, and carotenoid intake was determined using the USDA food databases. Models of logistic regression were applied to assess the association between obesity and overweight and dietary intake of carotenoids after adjusting for confounders.</p><p><strong>Results: </strong>Higher total carotenoid intake was associated with reduced risk of overweight (energy-adjusted OR: 0.647, 95% CI: 0.429-0.975, P = 0.037) and obesity (energy-adjusted OR: 0.395, 95% CI: 0.244-0.640, P < 0.001). Specific individual carotenoids, including β-carotene (OR: 0.510, 95% CI: 0.356-0.731, P < 0.001), lutein/zeaxanthin (OR: 0.479, 95% CI: 0.331-0.692, P < 0.001), and phytoene (OR = 0.450, 95% CI = 0.306-0.661, P < 0.001) exhibited stronger inverse associations compared to lycopene and astaxanthin.</p><p><strong>Conclusion: </strong>Diets rich in specific carotenoids, particularly β-carotene, lutein, and phytoene, may reduce the risk of both overweight and obesity. Future research ought to examine the mechanisms behind the relations of carotenoids with public health issues.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"23 1","pages":"14"},"PeriodicalIF":4.1,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12853827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-28DOI: 10.1186/s12986-026-01087-3
Feng Hu, Fayuan Fu, Hui Chen, Xinjie Zeng, Jing Wang, Chaoyang Lin, Yufang Jiang, Lin Fan, Yukun Luo
Background: The quantitative effects of integrating healthy lifestyles with depression on mortality remain unclear.
Methods: A total of 19, 528 individuals from NHANES and 75, 785 participants from the UK Biobank were analyzed. The associations between combined healthy lifestyle and depression with mortality were evaluated using Cox proportional hazards regression and Kaplan-Meier survival curves.
Results: There were 855 or 2,286 instances of all-cause death and 249 or 405 instances of cardiovascular death, respectively. Participants exhibiting healthier lifestyle choices or better depression status had a reduced risk of death. Moreover, individuals adhering to a favorable lifestyle and concurrently staying mentally healthy had a reduced risk of all-cause and cardiovascular death compared to their counterparts (adjusted-HR: 0.37, 95% CI 0.27 to 0.51 for all-cause death, P < 0.001; adjusted-HR: 0.42, 95% CI 0.23 to 0.77, P = 0.027 for cardiovascular death in the NHANES database; adjusted-HR: 0.33, 95% CI 0.27 to 0.40 for all-cause death, P < 0.001; adjusted-HR: 0.40, 95% CI 0.24 to 0.67, P = 0.002 for cardiovascular death in the UK Biobank). Additionally, the joint association of lifestyle and depression categories on cardiovascular mortality was modified by metabolic syndrome.
Conclusions: Subjects adhering to a favorable lifestyle and concurrently staying mentally healthy had a reduced risk of all-cause and cardiovascular death compared to their counterparts. This joint association of lifestyle and depression on cardiovascular mortality was modified by metabolic syndrome.
背景:将健康生活方式与抑郁相结合对死亡率的定量影响尚不清楚。方法:对来自NHANES的19,528名个体和来自UK Biobank的75,785名参与者进行分析。采用Cox比例风险回归和Kaplan-Meier生存曲线评估综合健康生活方式和抑郁与死亡率之间的关系。结果:全因死亡分别为855例和2286例,心血管死亡分别为249例和405例。表现出更健康的生活方式选择或更好的抑郁状态的参与者死亡风险降低。此外,坚持良好生活方式并同时保持心理健康的个体与对照组相比,全因死亡和心血管死亡的风险降低(调整后hr: 0.37, 95% CI 0.27 - 0.51)。结论:坚持良好生活方式并同时保持心理健康的受试者与对照组相比,全因死亡和心血管死亡的风险降低。这种生活方式和抑郁对心血管死亡率的联合关联被代谢综合征所改变。
{"title":"Association of healthy lifestyle, depression with all-cause or cardiovascular mortality modified by metabolic syndrome among individuals: evidence from US NHANES and UK biobank cohort studies.","authors":"Feng Hu, Fayuan Fu, Hui Chen, Xinjie Zeng, Jing Wang, Chaoyang Lin, Yufang Jiang, Lin Fan, Yukun Luo","doi":"10.1186/s12986-026-01087-3","DOIUrl":"10.1186/s12986-026-01087-3","url":null,"abstract":"<p><strong>Background: </strong>The quantitative effects of integrating healthy lifestyles with depression on mortality remain unclear.</p><p><strong>Methods: </strong>A total of 19, 528 individuals from NHANES and 75, 785 participants from the UK Biobank were analyzed. The associations between combined healthy lifestyle and depression with mortality were evaluated using Cox proportional hazards regression and Kaplan-Meier survival curves.</p><p><strong>Results: </strong>There were 855 or 2,286 instances of all-cause death and 249 or 405 instances of cardiovascular death, respectively. Participants exhibiting healthier lifestyle choices or better depression status had a reduced risk of death. Moreover, individuals adhering to a favorable lifestyle and concurrently staying mentally healthy had a reduced risk of all-cause and cardiovascular death compared to their counterparts (adjusted-HR: 0.37, 95% CI 0.27 to 0.51 for all-cause death, P < 0.001; adjusted-HR: 0.42, 95% CI 0.23 to 0.77, P = 0.027 for cardiovascular death in the NHANES database; adjusted-HR: 0.33, 95% CI 0.27 to 0.40 for all-cause death, P < 0.001; adjusted-HR: 0.40, 95% CI 0.24 to 0.67, P = 0.002 for cardiovascular death in the UK Biobank). Additionally, the joint association of lifestyle and depression categories on cardiovascular mortality was modified by metabolic syndrome.</p><p><strong>Conclusions: </strong>Subjects adhering to a favorable lifestyle and concurrently staying mentally healthy had a reduced risk of all-cause and cardiovascular death compared to their counterparts. This joint association of lifestyle and depression on cardiovascular mortality was modified by metabolic syndrome.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"23 1","pages":"29"},"PeriodicalIF":4.1,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146181437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-27DOI: 10.1186/s12986-025-01061-5
Saeid Hadi, Vahid Hadi, Milad Mohammadzadeh, Babak Jahangirfard
{"title":"Effects of melatonin supplementation on blood glycemic indices in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.","authors":"Saeid Hadi, Vahid Hadi, Milad Mohammadzadeh, Babak Jahangirfard","doi":"10.1186/s12986-025-01061-5","DOIUrl":"10.1186/s12986-025-01061-5","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"27"},"PeriodicalIF":4.1,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895708/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146065585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1186/s12986-026-01077-5
Madeline Bartsch, Linda Hemmelrath, Felix Kerlikowsky, Anja Bruns, Milena Burhop, Josefine Nebl, Theresa Greupner, Till Strowig, Till R Lesker, Lena Amend, Marius Vital, Shoma Berkemeyer, Andreas Hahn, Mattea Müller
Background: Diet is a determinant of metabolic health, partly through its effects on the gut microbiome, which influences nutrient metabolism, inflammation, and energy balance. We investigated the mediating role of gut microbiome features in the association between dietary quality and metabolic risk.
Methods: In this cross-sectional study, we included 269 adults aged 25-76 years with heterogeneous metabolic profiles, BMI ranging from 17.5 to 47.6 kg/m², and fasting glucose levels between 5.6 and 6.9 mmol/L. Dietary quality was assessed using the Healthy Eating Index (HEI-MON), the Planetary Health Diet Index (PHEI-MON), and the alternate Mediterranean Diet Score (aMED), derived from food-frequency questionnaires and three-day food records. Metabolic risk was quantified using a continuous metabolic syndrome score (cMetS) incorporating waist circumference, mean arterial pressure, HDL cholesterol, triglycerides, and fasting glucose. Microbiome composition (16 S rRNA gene sequencing) and predicted SCFA pathways were analyzed using adjusted multiple linear regression, PERMANOVA, and differential abundance analysis. Mediation analyses examined microbial features as potential mediators of the association between diet and metabolic risk.
Results: Higher HEI-MON, PHEI-MON, and aMED were associated with lower cMetS (q < 0.01). Christensenellaceae R7 group and Ruminococcaceae NK4A214 group were enriched with higher dietary quality and lower cMetS (q < 0.1), whereas Lachnoclostridium were associated with lower diet quality and higher cMetS (q < 0.1). The Enterotype Dysbiosis Score (EDS) correlated inversely with dietary quality (PHEI-MON q = 0.04) and positively with cMetS (q = 0.04). Butyrate-synthesis pathways were more abundant in individuals with higher dietary quality (q < 0.05) and inversely associated with cMetS (q < 0.05). Mediation analysis indicated that the Ruminococcaceae NK4A214 group, the Christensenellaceae R7 group, and Lachnoclostridium accounted for up to 16% of the association between diet and metabolic risk.
Conclusion: Better dietary quality is associated with lower metabolic risk and positive gut microbiome signatures across taxonomic, functional, and stability-related aspects. Certain taxa statistically mediated these associations, highlighting gut microbiome features that may contribute to observed links between dietary patterns and metabolic health.
{"title":"Gut microbiome mediates the association between dietary quality and metabolic risk in a heterogeneous adult population.","authors":"Madeline Bartsch, Linda Hemmelrath, Felix Kerlikowsky, Anja Bruns, Milena Burhop, Josefine Nebl, Theresa Greupner, Till Strowig, Till R Lesker, Lena Amend, Marius Vital, Shoma Berkemeyer, Andreas Hahn, Mattea Müller","doi":"10.1186/s12986-026-01077-5","DOIUrl":"10.1186/s12986-026-01077-5","url":null,"abstract":"<p><strong>Background: </strong>Diet is a determinant of metabolic health, partly through its effects on the gut microbiome, which influences nutrient metabolism, inflammation, and energy balance. We investigated the mediating role of gut microbiome features in the association between dietary quality and metabolic risk.</p><p><strong>Methods: </strong>In this cross-sectional study, we included 269 adults aged 25-76 years with heterogeneous metabolic profiles, BMI ranging from 17.5 to 47.6 kg/m², and fasting glucose levels between 5.6 and 6.9 mmol/L. Dietary quality was assessed using the Healthy Eating Index (HEI-MON), the Planetary Health Diet Index (PHEI-MON), and the alternate Mediterranean Diet Score (aMED), derived from food-frequency questionnaires and three-day food records. Metabolic risk was quantified using a continuous metabolic syndrome score (cMetS) incorporating waist circumference, mean arterial pressure, HDL cholesterol, triglycerides, and fasting glucose. Microbiome composition (16 S rRNA gene sequencing) and predicted SCFA pathways were analyzed using adjusted multiple linear regression, PERMANOVA, and differential abundance analysis. Mediation analyses examined microbial features as potential mediators of the association between diet and metabolic risk.</p><p><strong>Results: </strong>Higher HEI-MON, PHEI-MON, and aMED were associated with lower cMetS (q < 0.01). Christensenellaceae R7 group and Ruminococcaceae NK4A214 group were enriched with higher dietary quality and lower cMetS (q < 0.1), whereas Lachnoclostridium were associated with lower diet quality and higher cMetS (q < 0.1). The Enterotype Dysbiosis Score (EDS) correlated inversely with dietary quality (PHEI-MON q = 0.04) and positively with cMetS (q = 0.04). Butyrate-synthesis pathways were more abundant in individuals with higher dietary quality (q < 0.05) and inversely associated with cMetS (q < 0.05). Mediation analysis indicated that the Ruminococcaceae NK4A214 group, the Christensenellaceae R7 group, and Lachnoclostridium accounted for up to 16% of the association between diet and metabolic risk.</p><p><strong>Conclusion: </strong>Better dietary quality is associated with lower metabolic risk and positive gut microbiome signatures across taxonomic, functional, and stability-related aspects. Certain taxa statistically mediated these associations, highlighting gut microbiome features that may contribute to observed links between dietary patterns and metabolic health.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"13"},"PeriodicalIF":4.1,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12849433/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146011439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1186/s12986-025-01065-1
Yunhang Chu, Ming Yang, Qi Meng, Delong Cong, Lingyu Xu, Peng Dai, Ziqiang Chen, Sulan Chen, Rui Zhang, Yan Leng
<p><strong>Objective: </strong>Systematic evaluation of the efficacy and safety of lower-carbohydrate dietary patterns (LCDP) in metabolic associated fatty liver disease (MAFLD).</p><p><strong>Methods: </strong>The literature search was conducted in 8 databases, covering all relevant randomized controlled trials on LCDP intervention for MAFLD patients from the database establishment to June 1, 2025. The quality of the literature was evaluated using the Cochrane Bias Risk Assessment Tool. The extracted data were analyzed using Review Manager 5.3 software for meta-analysis. Sensitivity analysis and publication bias detection were performed using Stata 18.0 software.</p><p><strong>Results: </strong>The study included 9 randomized controlled trials (RCTs) that met the criteria, involving 408 MAFLD patients and covering 18 outcome measures related to anthropometry, liver function, blood pressure, blood lipids, and blood glucose. The study results indicate that LCDP can significantly affect the body weight (BW) and its 95% confidence intervals (CI) is -4.09 kg[-7.36, -0.81]; waist circumference (WC) -4.84 cm[-5.46, -4.23]; body mass index (BMI) -1.60 kg/m<sup>2</sup>[-2.41, -0.79]; diastolic blood pressure (DBP) -3.47mmHg[-5.23, -1.71]; triglycerides (TG) -0.45mmol/L[-0.73, -0.17]; fasting plasma glucose (FPG) -0.33mmol/L[-0.60, -0.06] and homeostatic model assessment of insulin resistance (HOMA-IR) -1.57[-2.52, -0.62] levels in patients with MAFLD. Subgroup analysis based on dietary subtypes showed that low carbohydrate diets (LCD) significantly affect the alanine aminotransferase (ALT) -6.82U/L[-12.15, -1.49] levels in MAFLD patients. Very low carbohydrate, high-fat ketogenic diets (VLCKD) can significantly affect the BW -4.62 kg[-8.10, -1.14]; WC -4.90 cm[-5.53, -4.28]; waist-to-hip ratio (WHR) -0.03[-0.05, -0.01]; BMI - 1.68 kg/m<sup>2</sup>[-2.64, -0.71]; TG -0.56mmol/L[-0.87, -0.24]; glycated hemoglobin (HbAlc) -0.61%[-1.13, -0.09] and HOMA-IR -2.27[-4.01, -0.54] in MAFLD patients. When the LCDP intervention cycle is 8 weeks, it may had no significant effect in MAFLD patients. When the intervention period is 12 weeks, it can significantly affect the BW -6.03 kg[-8.99, -3.07]; WC -4.88 cm[-5.50, -4.26]; BMI - 2.33 kg/m<sup>2</sup>[-2.61, -2.06]; HOMA-IR -1.44[-2.35, -0.52]; HbA1c -0.61%[-1.13, -0.09]; TG -0.50mmol/L[-0.98, -0.02]; aspartate transaminase (AST) -6.19U/L[-8.85, -3.54] and ALT - 17.09U/L[-26.40, -7.78] in MAFLD patients, and significantly affect the low-density lipoprotein cholesterol (LDL-C) + 0.22mmol/L[0.17, 0.27] in MAFLD patients. Adverse events were reported in 1 trial, commonly including dyspepsia, nausea, and found diet difficult to implement, etc. Although there is some heterogeneity in the study, the results are stable and there is no clear evidence of small-study effects.</p><p><strong>Conclusion: </strong>LCDP can improve obesity and insulin resistance (IR) in MAFLD patients, and has a layered mechanism for regulating bloo
{"title":"Efficacy and safety of lower-carbohydrate dietary patterns for metabolic associated fatty liver disease: evidence from randomized controlled trials with grade analysis.","authors":"Yunhang Chu, Ming Yang, Qi Meng, Delong Cong, Lingyu Xu, Peng Dai, Ziqiang Chen, Sulan Chen, Rui Zhang, Yan Leng","doi":"10.1186/s12986-025-01065-1","DOIUrl":"10.1186/s12986-025-01065-1","url":null,"abstract":"<p><strong>Objective: </strong>Systematic evaluation of the efficacy and safety of lower-carbohydrate dietary patterns (LCDP) in metabolic associated fatty liver disease (MAFLD).</p><p><strong>Methods: </strong>The literature search was conducted in 8 databases, covering all relevant randomized controlled trials on LCDP intervention for MAFLD patients from the database establishment to June 1, 2025. The quality of the literature was evaluated using the Cochrane Bias Risk Assessment Tool. The extracted data were analyzed using Review Manager 5.3 software for meta-analysis. Sensitivity analysis and publication bias detection were performed using Stata 18.0 software.</p><p><strong>Results: </strong>The study included 9 randomized controlled trials (RCTs) that met the criteria, involving 408 MAFLD patients and covering 18 outcome measures related to anthropometry, liver function, blood pressure, blood lipids, and blood glucose. The study results indicate that LCDP can significantly affect the body weight (BW) and its 95% confidence intervals (CI) is -4.09 kg[-7.36, -0.81]; waist circumference (WC) -4.84 cm[-5.46, -4.23]; body mass index (BMI) -1.60 kg/m<sup>2</sup>[-2.41, -0.79]; diastolic blood pressure (DBP) -3.47mmHg[-5.23, -1.71]; triglycerides (TG) -0.45mmol/L[-0.73, -0.17]; fasting plasma glucose (FPG) -0.33mmol/L[-0.60, -0.06] and homeostatic model assessment of insulin resistance (HOMA-IR) -1.57[-2.52, -0.62] levels in patients with MAFLD. Subgroup analysis based on dietary subtypes showed that low carbohydrate diets (LCD) significantly affect the alanine aminotransferase (ALT) -6.82U/L[-12.15, -1.49] levels in MAFLD patients. Very low carbohydrate, high-fat ketogenic diets (VLCKD) can significantly affect the BW -4.62 kg[-8.10, -1.14]; WC -4.90 cm[-5.53, -4.28]; waist-to-hip ratio (WHR) -0.03[-0.05, -0.01]; BMI - 1.68 kg/m<sup>2</sup>[-2.64, -0.71]; TG -0.56mmol/L[-0.87, -0.24]; glycated hemoglobin (HbAlc) -0.61%[-1.13, -0.09] and HOMA-IR -2.27[-4.01, -0.54] in MAFLD patients. When the LCDP intervention cycle is 8 weeks, it may had no significant effect in MAFLD patients. When the intervention period is 12 weeks, it can significantly affect the BW -6.03 kg[-8.99, -3.07]; WC -4.88 cm[-5.50, -4.26]; BMI - 2.33 kg/m<sup>2</sup>[-2.61, -2.06]; HOMA-IR -1.44[-2.35, -0.52]; HbA1c -0.61%[-1.13, -0.09]; TG -0.50mmol/L[-0.98, -0.02]; aspartate transaminase (AST) -6.19U/L[-8.85, -3.54] and ALT - 17.09U/L[-26.40, -7.78] in MAFLD patients, and significantly affect the low-density lipoprotein cholesterol (LDL-C) + 0.22mmol/L[0.17, 0.27] in MAFLD patients. Adverse events were reported in 1 trial, commonly including dyspepsia, nausea, and found diet difficult to implement, etc. Although there is some heterogeneity in the study, the results are stable and there is no clear evidence of small-study effects.</p><p><strong>Conclusion: </strong>LCDP can improve obesity and insulin resistance (IR) in MAFLD patients, and has a layered mechanism for regulating bloo","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"23 1","pages":"10"},"PeriodicalIF":4.1,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-17DOI: 10.1186/s12986-026-01084-6
Yuwei Wang
{"title":"Mendelian randomization identifies causal effects of phospholipids on portal vein thrombosis risk: FADS1/2-mediated pathways and their potential as diagnostic biomarkers.","authors":"Yuwei Wang","doi":"10.1186/s12986-026-01084-6","DOIUrl":"10.1186/s12986-026-01084-6","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"26"},"PeriodicalIF":4.1,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1186/s12986-026-01080-w
Aroosa Sultan, Muhammad Nadeem Akhtar, Anees Ahmed Khalil, Faiza Jameel, Suhas Ballal, Abhayveer Singh, Rajashree Panigrahi, Abhishek Sharma, Huda Ateeq, Areesha Ahmed, Fakhar Islam, Muhammad Afzaal, Catherine Tamale Ndagire
Background: Helicobacter pylori infection and oxidative stress are most common factors for development of gastric ulcers which is consider to be a most common gastrointestinal disorder. The main objective of this research was to evaluate the effects of avocado seeds aqueous extract as an adjunct to conventional ulcer treatment.
Methods: A randomized controlled trial was conducted with the participation of 99 patients diagnosed with gastric ulcers. Participants were randomly divided to a control group receiving standard medication and interventional group receiving the same treatment with avocado seeds aqueous extract. Screening and follow-up assessments assessment was performed by barium meal tests, radiological imaging, and serological markers, including H. pylori IgG and IgM (ELISA).
Results: Patients in the intervention group showed significant improvements in ulcer morphology and a marked reduction in H. pylori IgG and IgM levels compared with the control group (p < 0.05). Radiological findings also confirmed better mucosal healing in the supplemented group after 12 weeks of intervention.
Conclusions: Intervention group with avocado seeds aqueous extract showed a positive effect combined with conventional treatment, suggesting its potential as a natural adjunct therapy in management of gastric ulcers.
{"title":"Characterization of avocado seeds aqueous extract and its therapeutic effects on gastric ulcer.","authors":"Aroosa Sultan, Muhammad Nadeem Akhtar, Anees Ahmed Khalil, Faiza Jameel, Suhas Ballal, Abhayveer Singh, Rajashree Panigrahi, Abhishek Sharma, Huda Ateeq, Areesha Ahmed, Fakhar Islam, Muhammad Afzaal, Catherine Tamale Ndagire","doi":"10.1186/s12986-026-01080-w","DOIUrl":"10.1186/s12986-026-01080-w","url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori infection and oxidative stress are most common factors for development of gastric ulcers which is consider to be a most common gastrointestinal disorder. The main objective of this research was to evaluate the effects of avocado seeds aqueous extract as an adjunct to conventional ulcer treatment.</p><p><strong>Methods: </strong>A randomized controlled trial was conducted with the participation of 99 patients diagnosed with gastric ulcers. Participants were randomly divided to a control group receiving standard medication and interventional group receiving the same treatment with avocado seeds aqueous extract. Screening and follow-up assessments assessment was performed by barium meal tests, radiological imaging, and serological markers, including H. pylori IgG and IgM (ELISA).</p><p><strong>Results: </strong>Patients in the intervention group showed significant improvements in ulcer morphology and a marked reduction in H. pylori IgG and IgM levels compared with the control group (p < 0.05). Radiological findings also confirmed better mucosal healing in the supplemented group after 12 weeks of intervention.</p><p><strong>Conclusions: </strong>Intervention group with avocado seeds aqueous extract showed a positive effect combined with conventional treatment, suggesting its potential as a natural adjunct therapy in management of gastric ulcers.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"25"},"PeriodicalIF":4.1,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145990018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14DOI: 10.1186/s12986-026-01078-4
Faiyaz Ahmed, Bandar Moteb Almutairi, Saud Sulaiman Alharbi
{"title":"Impact of smartwatch data analytics on dietary consumption awareness among college students in Ar Rass, Al Qassim Region.","authors":"Faiyaz Ahmed, Bandar Moteb Almutairi, Saud Sulaiman Alharbi","doi":"10.1186/s12986-026-01078-4","DOIUrl":"10.1186/s12986-026-01078-4","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"24"},"PeriodicalIF":4.1,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13DOI: 10.1186/s12986-025-01073-1
Ting Xu, Yingqi Yang, Rong Xia, Jiahao Shen, Xiang Qi, Quan Wang, Zheng Zhu, Xichenhui Qiu, Qin Xu, Minghui Ji, Bei Wu
{"title":"Exploring gut microbiota mechanisms in frailty induced by 5-hydroxymethylfurfural: evidence from mouse models and Mendelian randomization.","authors":"Ting Xu, Yingqi Yang, Rong Xia, Jiahao Shen, Xiang Qi, Quan Wang, Zheng Zhu, Xichenhui Qiu, Qin Xu, Minghui Ji, Bei Wu","doi":"10.1186/s12986-025-01073-1","DOIUrl":"10.1186/s12986-025-01073-1","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"23"},"PeriodicalIF":4.1,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-11DOI: 10.1186/s12986-026-01079-3
Kaiya Xie, Yuqing Zhang, Lucas Ji Zong Yu, Xin Yu, Jiangbo He, Yingzhen Su
{"title":"Effects of Japan tallow on gut microbiota in type 2 diabetic mice.","authors":"Kaiya Xie, Yuqing Zhang, Lucas Ji Zong Yu, Xin Yu, Jiangbo He, Yingzhen Su","doi":"10.1186/s12986-026-01079-3","DOIUrl":"10.1186/s12986-026-01079-3","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":" ","pages":"19"},"PeriodicalIF":4.1,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12879351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}